Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Character displacement of a learned behaviour and its implications for ecological speciation.

Porter CK, Benkman CW.

Proc Biol Sci. 2019 Aug 14;286(1908):20190761. doi: 10.1098/rspb.2019.0761. Epub 2019 Jul 31.

PMID:
31362636
2.

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?

Giersing BK, Porter CK, Kotloff K, Neels P, Cravioto A, MacLennan CA.

Vaccine. 2019 Aug 7;37(34):4778-4783. doi: 10.1016/j.vaccine.2019.03.036.

3.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2019 Jul 1;129(7):2980. doi: 10.1172/JCI130874. Epub 2019 Jul 1. No abstract available.

4.

Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.

Porter CK, Riddle MS, Gutierrez RL, Princen F, Strauss R, Telesco SE, Torres J, Choung RS, Laird RM, Leon F, Colombel JF, Murray JA; PREDICTS study team.

Contemp Clin Trials Commun. 2019 Mar 26;14:100345. doi: 10.1016/j.conctc.2019.100345. eCollection 2019 Jun.

5.

Clinical endpoints for efficacy studies.

Porter CK, Gutierrez RL, Kotloff KL.

Vaccine. 2019 Aug 7;37(34):4814-4822. doi: 10.1016/j.vaccine.2019.03.051. Epub 2019 Apr 10.

6.

Hyperimmune bovine colostral anti-CS17 antibodies protect against enterotoxigenic Escherichia coli diarrhea in a randomized, doubled-blind, placebo-controlled human infection model.

Savarino SJ, McKenzie R, Tribble DR, Porter CK, O'Dowd A, Sincock SA, Poole ST, DeNearing B, Woods CM, Kim H, Grahek SL, Brinkley C, Crabb JH, Bourgeois AL.

J Infect Dis. 2019 Mar 21. pii: jiz135. doi: 10.1093/infdis/jiz135. [Epub ahead of print]

PMID:
30897198
7.

Campylobacter jejuni capsule types in a Peruvian birth cohort and associations with diarrhoeal disease severity.

Neitenbach B, Poly F, Kuroiwa J, Burga R, Olortegui MP, Guerry P, Kosek M, Porter CK.

Epidemiol Infect. 2019 Jan;147:e149. doi: 10.1017/S0950268818002960.

PMID:
30868983
8.

Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference?

Olson S, Hall A, Riddle MS, Porter CK.

Trop Dis Travel Med Vaccines. 2019 Jan 15;5:1. doi: 10.1186/s40794-018-0077-1. eCollection 2019.

9.

Montezuma's revenge - the sequel: The one-hundred year anniversary of the first description of "post-infectious" irritable bowel syndrome.

Riddle MS, Connor P, Porter CK.

World J Gastroenterol. 2018 Dec 7;24(45):5076-5080. doi: 10.3748/wjg.v24.i45.5076. Review.

10.

Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs.

Riddle MS, Ericsson CD, Gutierrez RL, Porter CK.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay099. No abstract available.

PMID:
30312427
11.

Update on Campylobacter vaccine development.

Poly F, Noll AJ, Riddle MS, Porter CK.

Hum Vaccin Immunother. 2019;15(6):1389-1400. doi: 10.1080/21645515.2018.1528410. Epub 2018 Oct 17.

12.

Post-Infectious Functional Gastrointestinal Disorders Among Populations Living in Areas of High Enteric Infection Risk: Adding Some Clarity or Further Muddying the Waters.

Riddle MS, Porter CK.

Am J Gastroenterol. 2018 Sep;113(9):1287-1289. doi: 10.1038/s41395-018-0206-5. Epub 2018 Sep 4.

PMID:
30185835
13.

Enterotoxigenic E. coli virulence gene regulation in human infections.

Crofts AA, Giovanetti SM, Rubin EJ, Poly FM, Gutiérrez RL, Talaat KR, Porter CK, Riddle MS, DeNearing B, Brubaker J, Maciel M Jr, Alcala AN, Chakraborty S, Prouty MG, Savarino SJ, Davies BW, Trent MS.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8968-E8976. doi: 10.1073/pnas.1808982115. Epub 2018 Aug 20.

14.

An Alternative to Adaptation by Sexual Selection: Habitat Choice.

Porter CK, Akcali CK.

Trends Ecol Evol. 2018 Aug;33(8):576-581. doi: 10.1016/j.tree.2018.05.004. Epub 2018 Jun 9.

PMID:
29895428
15.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2018 Aug 1;128(8):3298-3311. doi: 10.1172/JCI97659. Epub 2018 Jun 25. Erratum in: J Clin Invest. 2019 Jul 1;129(7):2980.

16.

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

Porter CK, Lynen A, Riddle MS, Talaat K, Sack D, Gutiérrez RL, McKenzie R, DeNearing B, Feijoo B, Kaminski RW, Taylor DN, Kirkpatrick BD, Bourgeois AL.

PLoS One. 2018 Mar 28;13(3):e0194325. doi: 10.1371/journal.pone.0194325. eCollection 2018.

17.

Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Crofts AA, Poly FM, Ewing CP, Kuroiwa JM, Rimmer JE, Harro C, Sack D, Talaat KR, Porter CK, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Maue AC, Jaep K, Alcala A, Tribble DR, Riddle MS, Ramakrishnan A, McCoy AJ, Davies BW, Guerry P, Trent MS.

Nat Microbiol. 2018 Apr;3(4):494-502. doi: 10.1038/s41564-018-0133-7. Epub 2018 Mar 27.

18.

Acute illness from Campylobacter jejuni may require high doses while infection occurs at low doses.

Teunis PFM, Bonačić Marinović A, Tribble DR, Porter CK, Swart A.

Epidemics. 2018 Sep;24:1-20. doi: 10.1016/j.epidem.2018.02.001. Epub 2018 Feb 8.

19.

The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites.

Blitz J, Riddle MS, Porter CK.

Front Microbiol. 2018 Jan 23;9:17. doi: 10.3389/fmicb.2018.00017. eCollection 2018.

20.

Epidemiology of Campylobacter Infections among Children in Egypt.

Sainato R, ElGendy A, Poly F, Kuroiwa J, Guerry P, Riddle MS, Porter CK.

Am J Trop Med Hyg. 2018 Feb;98(2):581-585. doi: 10.4269/ajtmh.17-0469. Epub 2017 Dec 14.

21.

Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.

Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS.

Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014.

PMID:
29145631
22.

Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.

Riddle MS, Connor P, Fraser J, Porter CK, Swierczewski B, Hutley EJ, Danboise B, Simons MP, Hulseberg C, Lalani T, Gutierrez RL, Tribble DR; TrEAT TD Study Team.

Clin Infect Dis. 2017 Nov 29;65(12):2008-2017. doi: 10.1093/cid/cix693.

23.

Comment on Van Belleghem et al. 2016: Habitat choice mechanisms in speciation and other forms of diversification.

Akcali CK, Porter CK.

Evolution. 2017 Nov;71(11):2754-2761. doi: 10.1111/evo.13375. Epub 2017 Oct 20.

PMID:
28975612
24.

Travelers' Diarrhea: An Update on the Incidence, Etiology, and Risk in Military Deployments and Similar Travel Populations.

Porter CK, Olson S, Hall A, Riddle MS.

Mil Med. 2017 Sep;182(S2):4-10. doi: 10.7205/MILMED-D-17-00064.

PMID:
28885918
25.

Review: chronic and persistent diarrhea with a focus in the returning traveler.

Duplessis CA, Gutierrez RL, Porter CK.

Trop Dis Travel Med Vaccines. 2017 May 4;3:9. doi: 10.1186/s40794-017-0052-2. eCollection 2017. Review.

26.

Giardia lamblia infection increases risk of chronic gastrointestinal disorders.

Dormond M, Gutierrez RL, Porter CK.

Trop Dis Travel Med Vaccines. 2016 Aug 30;2:17. doi: 10.1186/s40794-016-0030-0. eCollection 2016.

27.

Editorial: the Millennium study cohort-evaluating environmental determinates of IBD in the 21st Century. Authors' reply.

Porter CK, Riddle MS, Hooper TI.

Aliment Pharmacol Ther. 2017 Jul;46(1):64-65. doi: 10.1111/apt.14088. No abstract available.

28.

Developing and utilizing controlled human models of infection.

Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS.

Vaccine. 2017 Dec 14;35(49 Pt A):6813-6818. doi: 10.1016/j.vaccine.2017.05.068. Epub 2017 Jun 3.

29.

Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.

Savarino SJ, McKenzie R, Tribble DR, Porter CK, O'Dowd A, Cantrell JA, Sincock SA, Poole ST, DeNearing B, Woods CM, Kim H, Grahek SL, Brinkley C, Crabb JH, Bourgeois AL.

J Infect Dis. 2017 Jul 1;216(1):7-13. doi: 10.1093/infdis/jix144.

PMID:
28541500
30.

Assessing the Potential Contributions of Reduced Immigrant Viability and Fecundity to Reproductive Isolation.

Porter CK, Benkman CW.

Am Nat. 2017 May;189(5):580-591. doi: 10.1086/691191. Epub 2017 Mar 9.

PMID:
28410018
31.

Vaccination of active component US military personnel against Salmonella Typhi.

Porter CK, Sorrell T, Mitra I, Riddle MS.

Vaccine. 2017 Mar 27;35(14):1742-1748. doi: 10.1016/j.vaccine.2017.02.050. Epub 2017 Mar 6.

PMID:
28268075
32.

Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis.

Porter CK, Welsh M, Riddle MS, Nieh C, Boyko EJ, Gackstetter G, Hooper TI.

Aliment Pharmacol Ther. 2017 Apr;45(8):1115-1127. doi: 10.1111/apt.13991. Epub 2017 Feb 23.

33.

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.

Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, Weerts HE, Duplessis C, Castellano A, Alaimo C, Paolino K, Gormley R, Gambillara Fonck V.

Clin Vaccine Immunol. 2016 Dec 5;23(12):908-917. Print 2016 Dec.

34.

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis.

Choung RS, Princen F, Stockfisch TP, Torres J, Maue AC, Porter CK, Leon F, De Vroey B, Singh S, Riddle MS, Murray JA, Colombel JF; PREDICTS Study Team.

Aliment Pharmacol Ther. 2016 Jun;43(12):1300-10. doi: 10.1111/apt.13641. Epub 2016 Apr 27.

35.

Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents.

Rha B, Lopman BA, Alcala AN, Riddle MS, Porter CK.

PLoS One. 2016 Apr 26;11(4):e0148505. doi: 10.1371/journal.pone.0148505. eCollection 2016.

36.

Incidence and risk factors for disease and non-battle injury aboard the hospital ship USNS COMFORT during a Humanitarian Assistance and Disaster Response Mission, Continuing Promise 2011.

Chern A, McCoy A, Brannock T, Martin GJ, Scouten WT, Porter CK, Riddle MS.

Trop Dis Travel Med Vaccines. 2016 Apr 27;2:7. doi: 10.1186/s40794-016-0023-z. eCollection 2016.

37.

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Porter CK, Riddle MS, Alcala AN, Sack DA, Harro C, Chakraborty S, Gutierrez RL, Savarino SJ, Darsley M, McKenzie R, DeNearing B, Steinsland H, Tribble DR, Bourgeois AL.

PLoS One. 2016 Mar 3;11(3):e0149358. doi: 10.1371/journal.pone.0149358. eCollection 2016.

38.

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study.

Riddle MS, Welsh M, Porter CK, Nieh C, Boyko EJ, Gackstetter G, Hooper TI.

Am J Gastroenterol. 2016 Jan;111(1):93-104. doi: 10.1038/ajg.2015.386. Epub 2016 Jan 5.

39.

Typhoid fever cases in the U.S. military.

Sorrell T, Selig DJ, Riddle MS, Porter CK.

BMC Infect Dis. 2015 Oct 14;15:424. doi: 10.1186/s12879-015-1159-6.

40.

Perceived risk of watery diarrhea and dysentery and intended compliance with chemoprophylaxis among a deployed military population.

Porter CK, Felicione K, Tribble DR, Armstrong AW, Mostafa M, Riddle MS.

Trop Dis Travel Med Vaccines. 2015 Aug 19;1:7. doi: 10.1186/s40794-015-0009-2. eCollection 2015.

41.

Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010).

Gutiérrez RL, Riddle MS, Porter CK.

Gastroenterology. 2015 Nov;149(6):1408-14. doi: 10.1053/j.gastro.2015.07.059. Epub 2015 Aug 7.

PMID:
26255560
42.

Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study.

McCarroll MG, Riddle MS, Gutierrez RL, Porter CK.

Dig Dis Sci. 2015 Nov;60(11):3379-85. doi: 10.1007/s10620-015-3768-8. Epub 2015 Jun 27.

PMID:
26115751
43.

Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.

Pike BL, Paden KA, Alcala AN, Jaep KM, Gormley RP, Maue AC, Christmann BS, Elson CO, Riddle MS, Porter CK.

J Travel Med. 2015 Jul-Aug;22(4):242-50. doi: 10.1111/jtm.12218. Epub 2015 Jun 8.

44.

Establishment of Health Utility Indices for Post-Infectious Functional Gastrointestinal Disorders in Active Duty US Military.

Porter CK, Thura N, Schlett CD, Sanders JW, Tribble DR, Monteville MR, Riddle MS.

J Travel Med. 2015 Jul-Aug;22(4):237-41. doi: 10.1111/jtm.12200. Epub 2015 Apr 1.

45.

Relative cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against Campylobacter sp., ETEC, and Shigella sp.

Tallant A, Porter CK, Putnam SD, Tribble DR, Hooper TI, Riddle MS.

Vaccine. 2014 Sep 8;32(40):5156-62. doi: 10.1016/j.vaccine.2014.07.070. Epub 2014 Jul 30.

PMID:
25086264
46.

Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998-2010).

Gutiérrez RL, Riddle MS, Porter CK.

BMC Infect Dis. 2013 Dec 28;13:609. doi: 10.1186/1471-2334-13-609.

47.

A case-control study of incident rheumatological conditions following acute gastroenteritis during military deployment.

Deyoung KH, Riddle MS, May L, Porter CK.

BMJ Open. 2013 Dec 5;3(12):e003801. doi: 10.1136/bmjopen-2013-003801.

48.

Seroepidemiologic survey for Coxiella burnetii among US military personnel deployed to Southwest and Central Asia in 2005.

Royal J, Riddle MS, Mohareb E, Monteville MR, Porter CK, Faix DJ.

Am J Trop Med Hyg. 2013 Nov;89(5):991-5. doi: 10.4269/ajtmh.12-0174. Epub 2013 Sep 16.

49.

Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Deising A, Gutierrez RL, Porter CK, Riddle MS.

Gastroenterol Hepatol (N Y). 2013 Mar;9(3):145-57.

50.

Willingness to receive a hypothetical avian influenza vaccine among US military personnel in mid-deployment.

Porter CK, Fitamaurice G, Tribble DR, Armstrong AW, Mostafa M, Riddle MS.

Hum Vaccin Immunother. 2013 Dec;9(12):2613-7. doi: 10.4161/hv.25910. Epub 2013 Aug 5.

Supplemental Content

Loading ...
Support Center